EMC Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-31,090
| Closed | -$261K | – | 309 |
|
2025
Q1 | $261K | Hold |
31,090
| – | – | 0.16% | 107 |
|
2024
Q4 | $246K | Hold |
31,090
| – | – | 0.14% | 125 |
|
2024
Q3 | $259K | Hold |
31,090
| – | – | 0.17% | 118 |
|
2024
Q2 | $197K | Hold |
31,090
| – | – | 0.11% | 160 |
|
2024
Q1 | $188K | Sell |
31,090
-9,523
| -23% | -$57.6K | 0.11% | 178 |
|
2023
Q4 | $247K | Hold |
40,613
| – | – | 0.17% | 113 |
|
2023
Q3 | $171K | Buy |
40,613
+36,497
| +887% | +$154K | 0.13% | 151 |
|
2023
Q2 | $164 | Sell |
4,116
-36,497
| -90% | -$1.45K | 0.13% | 156 |
|
2023
Q1 | $56K | Hold |
40,613
| – | – | 0.05% | 249 |
|
2022
Q4 | $81K | Hold |
40,613
| – | – | 0.07% | 242 |
|
2022
Q3 | $82K | Hold |
40,613
| – | – | 0.08% | 218 |
|
2022
Q2 | $129K | Buy |
40,613
+196
| +0.5% | +$623 | 0.11% | 196 |
|
2022
Q1 | $156K | Buy |
+40,417
| New | +$156K | 0.11% | 149 |
|